Chronic Kidney Disease and Oxidative Stress

Marilena Stoian; Bogdan Gavrilă; Claudia Ciofu; Andrei Turbatu

doi:10.2478/inmed-2024-0298

Abstract

Disturbance of the balance between production of oxygen free radicals (or some other radical species) and activity of antioxidative system of protection causes the so called oxidative stress Protection of an organism from oxygen free radicals implies activity of enzymatic (catalase, SOD, glutathione peroxidase, glutathione reductase etc.) and nonenzymatic (vitamin E. vitamin C. glutathione, uric acid etc.) systems of protection. An organism can tolerate a mild oxidative stress but a higher disturbance between the production of free radicals and the activity of the antioxidative protection results in lipid protein and DNA as well as numerous diseases. In this article we analyze oxidative stress role as an important cofactor contributing to endothelial dysfunction, inflammation, atherosclerosis, glomerulosclerosis, anemia, tubulointerstitial nephritis and ischemia-reperfusion injury to chronic kidney disease patients.

References

Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun 2017; 482:426. DOI: 10.1016/j.bbrc.2016.11.088
Search in Google Scholar Back to article
West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011; 11:389. DOI: 10.1038/nri2975
Search in Google Scholar Back to article
Halliwell B.The role of oxygen radicals in human disease, with particuar reference to the vascular system . Haemostasis 1993;23(Suppl 1 ):118-126. DOI: 10.1159/000216921
Search in Google Scholar Back to article
Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney In 1994; 45:1–9. DOI: 10.1038/ki.1994.1
Search in Google Scholar Back to article
Klemm A, Voigt C, Friedrich M et al. Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance. Nephrol Dial Transplant 2001;16: 2166–2171, DOI: 10.1093/ndt/16.11.2166
Search in Google Scholar Back to article
Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 1999;31:261–272. DOI: 10.1080/1071576990 0300841.
Search in Google Scholar Back to article
Carr AC, McCall MR, Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species-reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000; 20:1716–1723. DOI: 10.1161/01.atv. 20.7.1716
Search in Google Scholar Back to article
Griendling KK, Sorescu D, Ushio‐Fukai M. NAD(P)H oxidase—role in cardiovascular biology and disease. Circ Res 2000; 86:494–501. DOI: 10.1161/01.res.86.5.494.
Search in Google Scholar Back to article
Vásquez‐Vivar J, Kalyanaraman B. Generation of superoxide from nitric oxide synthase. FEBS Letters 2000;481:305–306. DOI: 10.1016/s0014-5793(00) 02001-9.
Search in Google Scholar Back to article
Böger RH, Böde‐Boger SM, Phivthong‐ngam L et al. Dietary L‐arginine and α‐tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 1998;141:31–43.DOI: 10.1016/s0021-9150(98)00145-2.
Search in Google Scholar Back to article
Heitzer T, Brockhoff C, Mayer B et al. Tetrahydrobiopterin improves endothelium‐ dependent vasodilation in chronic smokers—evidence for a dysfunctional nitric oxide synthase. Circ Res 2000;86:E36–E41. DOI.org/10.1161/01.RES.86.2.e36
Search in Google Scholar Back to article
Dobashi K, Ghosh B, Orak JK, Singh I, Singh AK. Kidney ischemia‐reperfusion: modulation of antioxidant defenses. Mol Cell Biochem 2000; 205:1–11
Search in Google Scholar Back to article
Shackelford RE, Kaufmann WK, Paules RS. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 2000; 28: 1387–1404
Search in Google Scholar Back to article
Hannken T, Schroeder R, Zahner G, Stahl RAK, Wolf G. Reactive oxygen species stimulate p44/42 mitogen‐ activated protein kinase and induce p27Kip1: role in angiotensin II‐mediated hypertrophy of proximal tubular cells.J Am Soc Nephrol 2000; 11: 1387–1397
Search in Google Scholar Back to article
Berdeaux O, Scruel O, Durand T. Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: quantification methods. Pathol Biol. 2005;53:356–63.
Search in Google Scholar Back to article
Grzebyk E, Piwowar A. Inhibitory actions of selected natural substances on formation of advanced glycation end products and advanced oxidation protein products. Complement Altern Med. 2016;16:38–41
Search in Google Scholar Back to article
Butkowski EG, Al-Aubaidy HA, Jelinek HF. Interaction of homocysteine, glutathione and 8-hydroxy-2’-deoxyguanosine in metabolic syndrome progression. Clin Biochem. 2016;15:22–36.
Search in Google Scholar Back to article
Haleng J, Pincemail J, Defraigne JO, Charlier C, Chapelle JP. Le stress oxydant. Rev Med Liege. 2007;62:628–38.
Search in Google Scholar Back to article
Čolak E, Ignjatović S, Radosavljević A, Žorić L. The association of enzymatic and non-enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration. J Clin Biochem Nutr. 2017;60:100–7.
Search in Google Scholar Back to article
Bover J, Evenepoel P, Ureña-Torres P, et al. Pro: cardiovascular calcifications are clinically relevant. Nephrol Dial Transplant 2015; 30:345.
Search in Google Scholar Back to article
Zoccali C, London G. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. Nephrol Dial Transplant 2015; 30:352.
Search in Google Scholar Back to article
Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res 2016; 118:653.
Search in Google Scholar Back to article
Watanabe S, Fujii H, Kono K, et al. Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus. Sci Rep 2020; 10:20708.
Search in Google Scholar Back to article
Wei R, Enaka M, Muragaki Y. Activation of KEAP1/NRF2/P62 signaling alleviates high phosphate-induced calcification of vascular smooth muscle cells by suppressing reactive oxygen species production. Sci Rep 2019; 9:10366.
Search in Google Scholar Back to article
Witko-Sarsat V, Drüeke T, Descamps-Latscha B, Canteloup S. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524–32.
Search in Google Scholar Back to article
Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Atherosclerosis as an inflammatory disease. Curr Pharm Des. 2012;18:4266–88.
Search in Google Scholar Back to article
Schmitz G, Herr AS, Rothe G. T-lymphocytes and monocytes in atherogenesis. Herz. 1998;23:168–77.
Search in Google Scholar Back to article
Ikeda U, Takahashi M, Shimada K. Monocyteendothelial cell interaction in atherogenesis and thrombosis. Clin Cardiol. 1998;21:11–4.
Search in Google Scholar Back to article
Descamps-Latscha B, Witko-Sarsat V. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis. 2005;45:39–47.
Search in Google Scholar Back to article
Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401.
Search in Google Scholar Back to article
Migdal C, Serres M. Especes reactives de l’oxygene et stress oxydant. Med Sci. 2011;27:405–12.
Search in Google Scholar Back to article
Maziere C, Gomila C, Maziere JC. Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress. Free Radic Biol Med. 2010;48:1382–7.
Search in Google Scholar Back to article
Beaudeux JL, Peynet J, Bonnefont-Rousselot D, et al. Cellular sources of reactive oxygen and nitrogen species. Roles in signal transcription pathways. Ann Pharm Fr. 2006;64:373–81.
Search in Google Scholar Back to article
Bogna G, Dorota F, Magdalena B, et al. Advanced oxidation protein products and carbonylated proteins as biomarkers of oxidative stress in selected atherosclerosis-mediated diseases. Biomed Res Int. 2017;20:487–97.
Search in Google Scholar Back to article
Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res. 2009;82:9–20.
Search in Google Scholar Back to article
Beaudeux JL, Dellatre J, Therond P, Bonnefont-Rousselot D, Legrand G, Peynet J. Le stress oxydant, composante physiopathologique de l’athérosclérose. Immuno-analyse Biologie Spécialisée. 2006;21:144–50.
Search in Google Scholar Back to article
Choi B, Kang KS, Kwak MK. Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules. 2014;19:12727–59.
Search in Google Scholar Back to article
Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expressionof interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelialcells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 2002;195:245–57.
Search in Google Scholar Back to article
Shen G, Jing L. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chron Dis Transl Med. 2017;3:89–94
Search in Google Scholar Back to article
Meier P, Spertini F, Blanc E, Burnier M. Oxidized low density lipoproteins activate CD4+ T cell apoptosis in patients with end-stage renal disease through Fas engagement. Am Soc Nephrol. 2007;18:331–42.
Search in Google Scholar Back to article
Kita T, Kume N, Minami M, et al. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci. 2001;947:199–205.
Search in Google Scholar Back to article
Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115:610.DOI: 10.1172/JCI23056
Search in Google Scholar Back to article
Scindia Y, Dey P, Thirunagari A, et al. Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis. J Am Soc Nephrol 2015; 26:2800. DOI: 10.1681/ASN.2014101037.
Search in Google Scholar Back to article
Klahr S. Oxygen radicals and renal diseases.Miner Electrolyte Metab1997; 23:140–143.
Search in Google Scholar Back to article
Witko Sarsat V, Friedlander M, Capeillere Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304–1313
Search in Google Scholar Back to article
Cristol JP, Bosc JY, Badiou S et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial transplant 1997; 12: 2312–2317
Search in Google Scholar Back to article
Beutler E, Dale GL. Erythrocyte glutathione. In: Dolphin D, Avramovic O, Poulson R, eds. Glutathione: Biochemical and Medical Aspects. Part B. John Wiley & Sons, New York, 1989; 291
Search in Google Scholar Back to article
Biasioli S, Schiavon R, De Fanti E, Cavalcanti G, Giavarina D. The role of erythrocytes in the deperoxidative processes in people on hemodialysis. ASAIO J 1996; 42: M890–M894
Search in Google Scholar Back to article
Costagliola C, Romano L, Sorice P, Di‐Benedetto A. Anemia and chronic renal failure: the possible role of the oxidative state of glutathione. Nephron1989; 52: 11–14
Search in Google Scholar Back to article
Ceballos‐Picot I, Witko‐Sarsat V, Merad‐Boudia M et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol red 1996; 21:845–853
Search in Google Scholar Back to article
Canestrari F, Galli F, Giorgini A et al. Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol 1994; 91: 187–193
Search in Google Scholar Back to article
Chu P, Cadley M, Bellingham AJ. Red cell metabolism in renal failure—the effect of dialysis. Clin Lab Haemat 1985; 7: 1–5
Search in Google Scholar Back to article
Yawata Y, Jacob HS. Abnormal red cell metabolism in patients with chronic uraemia—nature of the defect and its persistence despite adequate hemodialysis. Blood 1975; 45: 231–239
Search in Google Scholar Back to article
Ansley DM, Sun J, Visser WA et al. High dose propofol enhances red cell antioxidant capacity during CPB in humans.Can J Anaesth 1999; 46: 641–648
Search in Google Scholar Back to article
Repetto MG, Reides CG, Evelson P, Kohan S, de-Lustig ES, Llesuy SF. Peripheral markers of oxidative stress in probable Alzheimer patients.Eur J Clin Invest 1999; 29:643–649
Search in Google Scholar Back to article
Maples KR, Kennedy CH, Jordan SJ, Mason RP. In vivo thiyl free radical formation from hemoglobin following administration of hydroperoxides. Arch Biochem Biophys 1990; 277: 402–409
Search in Google Scholar Back to article
Gwozdzinski K, Janicka M, Brzeszczynska J, Luciak M. Changes in red blood cell membrane structure in patients with chronic renal failure.Acta Biochim Pol 1997;44 :99–107.
Search in Google Scholar Back to article

Chronic Kidney Disease and Oxidative Stress

Abstract

Paradigm

My account